| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 03/25/2004 | CA2494274A1 Method and composition for regulating the activity of regulatory t cells |
| 03/24/2004 | EP1400534A1 Human CD3-specific antibody with immunosuppressive properties |
| 03/24/2004 | EP1400530A1 Suppression of immune response via inhibition of cathepsin S |
| 03/24/2004 | EP1400521A1 Piperazine compounds |
| 03/24/2004 | EP1400518A1 Heterocyclic compound derivatives and medicines |
| 03/24/2004 | EP1400515A1 Cyclic diamine compound having five-membered cyclic group |
| 03/24/2004 | EP1400513A1 Unsymmetrical cyclic diamine compound |
| 03/24/2004 | EP1400510A1 Cyclic diamine compounds having fused-ring groups |
| 03/24/2004 | EP1400174A1 Method of sterilizing antibody-containing milk and products containing sterilized antibody-containing milk |
| 03/24/2004 | EP1399744A2 Epf receptor assays, compounds and therapeutic compositions |
| 03/24/2004 | EP1399570A2 Peptides for use as translocation factors |
| 03/24/2004 | EP1399556A2 Antigenic epitopes of factor viii, inhibitors directed against said epitopes and use thereof |
| 03/24/2004 | EP1399554A2 Immunoglobulin superfamily proteins |
| 03/24/2004 | EP1399548A2 Conjugate of a transport protein and a protein for modulation of notch signalling |
| 03/24/2004 | EP1399537A2 Therapeutic polypeptides, nucleic acids encoding same and methods of use |
| 03/24/2004 | EP1399480A2 Multimers of class i major histocompatibility complexes containing modified beta2-microglobulin proteins |
| 03/24/2004 | EP1399479A2 Cation conducting gaba a receptors and their use |
| 03/24/2004 | EP1399447A1 Imidazotriazinones derivatives and their use against inflammatory processes and/or immune diseases |
| 03/24/2004 | EP1399441A1 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 03/24/2004 | EP1399440A1 5-(2-aminopyrimidin-4-yl)benzisoxazoles as protein kinase inhibitors |
| 03/24/2004 | EP1399439A1 2-heteroaryl-imidazotriazinones and their use in the treatment of inflammatory or immune diseases |
| 03/24/2004 | EP1399435A2 Pyridine derivatives useful as cd40:cd154 binding interruptors and use thereof to treat immunological complications |
| 03/24/2004 | EP1399433A2 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 03/24/2004 | EP1399431A2 Novel nitriles useful as reversible inhibitors of cysteine proteases |
| 03/24/2004 | EP1399420A2 Pyrrolidines as dipeptidyl peptidase inhibitors |
| 03/24/2004 | EP1399406A2 Novel estrogen receptor ligands and methods i |
| 03/24/2004 | EP1399215A2 Tissue-specific endothelial membrane proteins |
| 03/24/2004 | EP1399203A1 Nasal drug delivery devices |
| 03/24/2004 | EP1399185A2 Use of polyclonal immunoglobulins as vaccine |
| 03/24/2004 | EP1399184A2 Uses of mammalian genes and related reagents |
| 03/24/2004 | EP1399183A2 Chimeric alphavirus replicon particles |
| 03/24/2004 | EP1399173A2 Pharmaceutical preparation containing active ingredients extracted from the plants centella asiatica, mahonia aquifolium and viola tricolor |
| 03/24/2004 | EP1399162A2 Treating neuropathic/inflammatory pain by targeting a composition (e.g. zd7288) to hcn pacemaker channels |
| 03/24/2004 | EP1399159A1 4-substituted-1-(arylmethylidene)thiosemicarbazide, 4-substituted-1-(arylcarbonyl)thiosemicarbazide and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 03/24/2004 | EP1399155A2 Small molecules useful in the treatment of inflammatory disease |
| 03/24/2004 | EP1399154A1 3-fluoro-pyrrolidines as antidiabetic agents |
| 03/24/2004 | EP1399151A2 A method for treating inflammatory diseases by administering a ppar-delta agonist |
| 03/24/2004 | EP1399147A2 Therapeutic delivery of carbon monoxide |
| 03/24/2004 | EP1399140A1 Biological response modifier composition and uses thereof |
| 03/24/2004 | EP1399127A1 Olopatadine formulations for topical administration |
| 03/24/2004 | EP1303517B1 Indoloquinazolinones |
| 03/24/2004 | EP1252164B1 Method for producing 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1h-pyrrolizine-5-yl acetic acid |
| 03/24/2004 | EP1161232B1 Hydroxy diphenyl urea sulfonamides as il-8 receptor antagonists |
| 03/24/2004 | EP1150693B1 Immunogenic compositions for use as vaccines |
| 03/24/2004 | EP1140895B1 Thiopyran compounds as inhibitors of mmp |
| 03/24/2004 | EP1124809B1 Benzoylpyridazines |
| 03/24/2004 | EP0957930B1 Substance p treatment for immunostimulation |
| 03/24/2004 | EP0946592B1 Immuno-reactive peptide ctl epitopes of human cytomegalovirus |
| 03/24/2004 | EP0922036B1 Arylalkanoyl pyridazines |
| 03/24/2004 | EP0777494B1 Human chemokine polypeptides |
| 03/24/2004 | CN1484699A Novel mutant allergens |
| 03/24/2004 | CN1484652A Antibodies to human IL-1 beta |
| 03/24/2004 | CN1484644A Novel 7-azaindoles use thereof as phosphodiesterase 4 inhibitors and method for producing the same |
| 03/24/2004 | CN1484537A Pharmacentical preparation for douches and/or irrigations of natural or puthological cavities in human body |
| 03/24/2004 | CN1484533A Combined use of enzyme inhibitors and pharmaceutical preparations thereof for the treatment and prophylaxis of arteriosclerosis for the treatment and prevention of |
| 03/24/2004 | CN1484532A Pharmaceutical compositions enhancing the immunogenicity of poorly immunogenic antigens |
| 03/24/2004 | CN1484526A Perturbed membrane-binding compounds |
| 03/24/2004 | CN1483801A Health care wine containing dihydro-myricetin and myricetin composition |
| 03/24/2004 | CN1483731A Aqueous triptolide alcohol derivative with high immunesuppressive activity and its application |
| 03/24/2004 | CN1483477A Vaccin composition, preparation method and use thereof |
| 03/24/2004 | CN1483475A Combined bacterin for treating allergic disease and preparation method |
| 03/24/2004 | CN1483450A Nutritious health care food and preparation prlcess thereof |
| 03/24/2004 | CN1483444A Formula of rehmannia root effervescence preparation and process for preparing same |
| 03/24/2004 | CN1142920C Quinazoline derivatives and pharmaceutical compositions containing them and preparation process and use |
| 03/24/2004 | CN1142912C Amide derivs, useful as inhibitors for production of cytokines |
| 03/24/2004 | CN1142909C Indole derivatives with antiviral activity |
| 03/23/2004 | US6710165 Membrane protein for use in the treatment of allergies, parkinson's, alzheimer's and apoptitic defects |
| 03/23/2004 | US6710080 Substituted 2-dialkylaminoalkylbiphenyl derivatives |
| 03/23/2004 | US6710067 Mannich base prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives |
| 03/23/2004 | US6710054 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 03/23/2004 | US6710052 Anticancer agents |
| 03/23/2004 | US6709831 DNA encoding mammalian neuropeptide FF (NPFF) receptors and uses thereof |
| 03/23/2004 | US6709676 Bilayer solid comprising an immediate release first layer of desloratadine, and an antioxidant or group 2a or aluminum salts and excipient, and a sustained release second layer of nasal decongestant such as pseudoephedrine sulfate |
| 03/23/2004 | US6709654 Treatment of psoriasis using anti-B7.1 (CD80) antibodies |
| 03/23/2004 | US6709649 RANTES derived peptides with anti-HIV activity |
| 03/23/2004 | CA2350074C Aerosols comprising nanoparticle drugs |
| 03/23/2004 | CA2263319C Quinazoline derivatives and pharmaceutical compositions containing them |
| 03/18/2004 | WO2004023138A1 Method of screening remedy for aids |
| 03/18/2004 | WO2004022761A1 Retroviral vector and stable packaging cell lines |
| 03/18/2004 | WO2004022729A1 Method for the cultivation of primary cells and for the amplification of viruses under serum free conditions |
| 03/18/2004 | WO2004022727A1 Probiotic bacterium: lactobacillus fermentum |
| 03/18/2004 | WO2004022716A2 Recombinatant mutants of rhabdovirus and methods of use thereof |
| 03/18/2004 | WO2004022697A2 Denaturat stable and/or protease resistant, chaperone-like oligomeric proteins, polynucleotides encoding same, their uses and methods of increasing a specific activity thereof |
| 03/18/2004 | WO2004022657A2 Increasing of the resorption of substances via skin and mucous membranes |
| 03/18/2004 | WO2004022562A1 6-ARYL-IMIDAZO[1,2-a]PYRAZIN-8-YLAMINES, METHOD OF MAKING, AND METHOD OF USE THEREOF |
| 03/18/2004 | WO2004022557A1 Novel benzonaphthyridines |
| 03/18/2004 | WO2004022553A1 INDOLE OR BENZIMIDAZOLE DERIVATIVES FOR MODULATING IκB KINASE |
| 03/18/2004 | WO2004022551A1 Furan or thiophene derivative and medicinal use thereof |
| 03/18/2004 | WO2004022544A1 Novel aminoindazole derivatives as medicines and pharmaceutical compositions containing same |
| 03/18/2004 | WO2004022535A1 Acrylamide derivatives |
| 03/18/2004 | WO2004022529A2 Diarylurea derivatives and their use as chloride channel blockers |
| 03/18/2004 | WO2004022128A2 Liquid aerosol formulations and aerosol generating devices and methods for generating aerosols |
| 03/18/2004 | WO2004022124A1 Medical device having hydration inhibitor |
| 03/18/2004 | WO2004022084A1 A method of modulating cellular activity and molecules for use therein |
| 03/18/2004 | WO2004022082A1 Embryo implantation inhibitor |
| 03/18/2004 | WO2004022079A1 Method for reinstalling control system for antigenic homeostasis of mammalian organisms (effect of kukharchuk-radchenko-sirman) |
| 03/18/2004 | WO2004022061A1 Use of indolyl derivatives for the manufacture of a medicament for the treatment allergic rhinitis |
| 03/18/2004 | WO2004021999A2 Use of histamine h4 receptor modulators for the treatment of allergy and asthma |
| 03/18/2004 | WO2004009596A3 Pyrazolopyrimidines as kinase inhibitors |
| 03/18/2004 | WO2004000204A8 Labelled somatostatin analogs backbone cyclized through metal complexation |